| Peter Winston, MD | |
|
6900 Orchard Lake Rd, Suite 101, West Bloomfield, MI 48322-3405 | |
| (248) 539-9036 | |
| Not Available |
| Full Name | Peter Winston |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 48 Years |
| Location | 6900 Orchard Lake Rd, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447395751 | NPI | - | NPPES |
| PW038127 | Other | MI | BLUE SHIELD |
| P01398044 | Other | MI | RAILROAD MEDICARE |
| 0176814 | Other | MI | TOTAL HEALTH CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | 4301038127 (Michigan) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 4301038127 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Institute Of Urology Pc | 1052223492 | 76 |
| Arcturus Healthcare Plc | 7012143118 | 63 |
News Archive
"Nicaragua is heading for presidential elections, and among the issues dividing people in this mostly Catholic country is abortion," with advocates marching in the streets of the capital Managua to show support for overturning a ban on therapeutic abortions that was instituted five years ago, Al Jazeera reports.
The safety concerns associated with electroconvulsive therapy (ECT) are unwarranted, according to a new study in Frontiers in Psychology.
A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
› Verified 3 days ago
| Entity Name | Michigan Institute Of Urology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427027416 PECOS PAC ID: 1052223492 Enrollment ID: O20031125000770 |
News Archive
"Nicaragua is heading for presidential elections, and among the issues dividing people in this mostly Catholic country is abortion," with advocates marching in the streets of the capital Managua to show support for overturning a ban on therapeutic abortions that was instituted five years ago, Al Jazeera reports.
The safety concerns associated with electroconvulsive therapy (ECT) are unwarranted, according to a new study in Frontiers in Psychology.
A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
› Verified 3 days ago
| Entity Name | Midwest Diagnostic Imaging, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538178934 PECOS PAC ID: 3274597158 Enrollment ID: O20041119000357 |
News Archive
"Nicaragua is heading for presidential elections, and among the issues dividing people in this mostly Catholic country is abortion," with advocates marching in the streets of the capital Managua to show support for overturning a ban on therapeutic abortions that was instituted five years ago, Al Jazeera reports.
The safety concerns associated with electroconvulsive therapy (ECT) are unwarranted, according to a new study in Frontiers in Psychology.
A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
› Verified 3 days ago
| Entity Name | Arcturus Healthcare Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326487901 PECOS PAC ID: 7012143118 Enrollment ID: O20131120000330 |
News Archive
"Nicaragua is heading for presidential elections, and among the issues dividing people in this mostly Catholic country is abortion," with advocates marching in the streets of the capital Managua to show support for overturning a ban on therapeutic abortions that was instituted five years ago, Al Jazeera reports.
The safety concerns associated with electroconvulsive therapy (ECT) are unwarranted, according to a new study in Frontiers in Psychology.
A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Winston, MD 20952 E 12 Mile Rd, Suite 200, Saint Clair Shores, MI 48081-3200 Ph: (586) 771-4820 | Peter Winston, MD 6900 Orchard Lake Rd, Suite 101, West Bloomfield, MI 48322-3405 Ph: (248) 539-9036 |
News Archive
"Nicaragua is heading for presidential elections, and among the issues dividing people in this mostly Catholic country is abortion," with advocates marching in the streets of the capital Managua to show support for overturning a ban on therapeutic abortions that was instituted five years ago, Al Jazeera reports.
The safety concerns associated with electroconvulsive therapy (ECT) are unwarranted, according to a new study in Frontiers in Psychology.
A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
› Verified 3 days ago
Dr. Sheil Shah, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2614 Comfort St, West Bloomfield, MI 48323 Phone: 248-214-6934 | |
Dr. Harvey Minkin, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7001 Orchard Lake Rd, Suite 122, West Bloomfield, MI 48322 Phone: 248-932-5100 | |
Mark G. Weingarden, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: Henry Ford Health System, 6777 West Maple Road, West Bloomfield, MI 48323 Phone: 248-661-6450 Fax: 248-661-6649 | |
Dr. James Gamero, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2625 Elizabeth Ln, West Bloomfield, MI 48324 Phone: 248-366-0007 Fax: 248-366-7913 | |
Steven Lewin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3775 Orchard Lake Rd Apt 103, West Bloomfield, MI 48324 Phone: 248-408-9023 Fax: 248-681-9187 | |
Mark L Camens, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3210 Legacy Ct, West Bloomfield, MI 48323 Phone: 855-687-7237 Fax: 855-673-9190 |